Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose

NCT01978028 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment

Conditions

Heart Failure

Interventions

DRUG: ferric carboxymaltose
DRUG: placebo

Sponsor

University of Zurich